Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, No. 16 Nanxiao Lane, Dongzhimennei, Beijing 100700, China; Weifang No. 2 People's Hospital, No. 7 College Street, Kuiwen District, Weifang, Shandong Province, China.
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, No. 16 Nanxiao Lane, Dongzhimennei, Beijing 100700, China.
J Ethnopharmacol. 2024 Feb 10;320:117348. doi: 10.1016/j.jep.2023.117348. Epub 2023 Nov 8.
Rhubarb, a prominent traditional Chinese medicine, has been employed as a potent laxative for centuries and garnered particular popularity among the youth owing to its notable efficacy in weight management. Historical records indicated that rhubarb initially exhibited robust laxative properties, but extended and consistent usage may lead to an astringent response in the later stage of long-term use. In contrast, steamed pieces of rhubarb (SR), preparing through the process of steaming with wine, have demonstrated a gentle laxative effect with no reported adverse effects.
Our study was designed to explore the intricate mechanisms underlying laxative and astringent properties of rhubarb through metabolomics research.
In this investigation, we employed a serum metabolomics approach utilizing the UPLC-Q-Extractive-Orbitrap-MS method to delve into the contrasting laxative and astringent effects of rhubarb, as well as to unravel the mechanisms of underpinning its bidirectional regulatory influence. To commence, we assessed alterations in Evacuation Index (EI) values, intestinal hormone levels, and colon histopathology in mice to gauge rhubarb's laxative and astringent effects. Subsequently, metabolomics methodology was employed for cluster analysis through Principal Component Analysis (PCA) and biomarker identification via Orthogonal Partial Least Squares-Discriminant Analysis (OPLS-DA). Then, we delved into the distinctions in characteristic biomarkers, metabolic pathways, their association with pathological changes, and correlation heatmap for biomarkers between raw pieces of rhubarb (RR) and SR to gain insights into the potential mechanisms behind rhubarb's bidirectional regulatory effects.
Our findings revealed that RR exhibited a laxative effect in the early stage and transitioned to an astringent effect in the later stage, as indicated by the EI values. In contrast, SR consistently demonstrated a mild laxative effect. Biochemical indexes and histopathological assessments unveiled that RR triggered its astringent effect by inhibiting secretion of motilin (MTL), promoting secretion of vasoactive intestinal peptide (VIP) and epinephrine (EPI), and inducing onset of inflammation. Furthermore, serum metabolomics analysis identified 59 discriminative biomarkers modulated by RR and SR. Through comprehensive analysis, we elucidated the in vivo transformation relationships among multiple endogenous metabolites. Notably, our results underscored the down-regulation of certain phosphatidylcholines (PCs), amino acids, acylcarnitines, and up-regulation of lysophosphatidylcholines (LysoPCs) played pivotal roles in the onset of gut dysfunction, intestinal inflammation, gut barrier damage, and gastrointestinal motility disorder upon prolonging RR administration, ultimately contributing to its astringent effect. Additionally, our correlation analysis elucidated that anthraquinones, stilbenes, and phenylbutanones were the pharmacodynamic material basis responsible for inducing the astringent effect of RR.
This study provides valuable insights into the bidirectional regulatory effects of rhubarb and sheds light on its underlying mechanisms through a comprehensive metabolomics approach.
大黄作为一种重要的中药,已有数百年的历史,被用作强力泻药,尤其在体重管理方面,因其显著的疗效而受到年轻人的特别欢迎。历史记载表明,大黄最初表现出很强的泻下作用,但长期持续使用可能会导致后期出现收敛作用。相比之下,经过酒蒸炮制的制大黄(SR)具有温和的泻下作用,且没有报道不良反应。
本研究旨在通过代谢组学研究探讨大黄泻下和收敛作用的复杂机制。
在这项研究中,我们采用血清代谢组学方法,利用 UPLC-Q-Extractive-Orbitrap-MS 方法,深入研究大黄的泻下和收敛作用的差异,并揭示其双向调节影响的机制。首先,我们评估了大黄对小鼠的排便指数(EI)值、肠激素水平和结肠组织病理学的影响,以评估大黄的泻下和收敛作用。然后,我们通过主成分分析(PCA)进行聚类分析,通过正交偏最小二乘判别分析(OPLS-DA)进行生物标志物鉴定。接着,我们研究了生大黄(RR)和制大黄(SR)之间特征性生物标志物、代谢途径的差异,及其与病理变化的关系,并对生物标志物进行相关热图分析,以深入了解大黄双向调节作用的潜在机制。
我们的发现表明,RR 在早期表现出泻下作用,后期则表现出收敛作用,这可以通过 EI 值来衡量。相比之下,SR 始终表现出温和的泻下作用。生化指标和组织病理学评估揭示,RR 通过抑制胃动素(MTL)的分泌、促进血管活性肠肽(VIP)和肾上腺素(EPI)的分泌以及诱导炎症来发挥其收敛作用。此外,血清代谢组学分析鉴定了 59 种受 RR 和 SR 调节的差异生物标志物。通过综合分析,我们阐明了多种内源性代谢物之间的体内转化关系。值得注意的是,我们的研究结果表明,某些磷脂酰胆碱(PCs)、氨基酸、酰基辅酶 A 和溶血磷脂酰胆碱(LysoPCs)的下调在延长 RR 给药后肠道功能障碍、肠道炎症、肠道屏障损伤和胃肠道动力障碍的发生中起着关键作用,最终导致其收敛作用。此外,我们的相关性分析表明,蒽醌类、二苯乙烯类和苯丁酮类是诱导 RR 收敛作用的药效物质基础。
本研究通过全面的代谢组学方法,为大黄的双向调节作用提供了有价值的见解,并阐明了其潜在机制。